Synopsis
Green chemistry is an increasingly important topic of research which sees scientists striving to develop new strategies to minimise the impact of organic chemistry on the environment. This one-day symposium brings together industrial and academic experts to present some cutting edge synthetic approaches towards sustainable chemistry. The application of green chemistry in the discovery and development of novel pharmaceutical drugs will also be discussed.
Attendees
The meeting will be of interest to all synthetic, organic, medicinal and process chemists. Seasoned green chemists, those with an interest in learning more about green chemistry and also those sceptical of its application should attend.
Programme
Day 1
- 09:30
- Registration and refreshments
- 1000
- Plenary lecture: green chemistry, biocatalysis and environmental assessment
Peter Dunn, Pfizer
- 10:45
- Green chemistry metrics
Rob McElroy, University of York
- 11:15
- Refreshment break
- 11:45
- An overview of green chemistry tools available from the ACS green chemistry pharma roundtable
Barry Dillon, AstraZeneca
- 12:15
- Nick Turner, University of Manchester
- 12:45
- Lunch
- 14:00
- Hon Lam, University of Nottingham
- 14:30
- Selective fluorination for greener synthesis of pharmaceuticals
Graham Sandford, University of Durham
- 15:00
- Early Process Research: An opportunity for Advances in Green Chemistry
Fabrice Gallou, Novartis
- 15:30
- Refreshment break
- 16:00
- Synthesis by flow reactors; technology and chemical innovation
Ian Baxendale, University of Durham
- 16:30
- Panel discussion
- 17:00
- Close
Venue and Contact
Fees
This event is FREE to attend.
Become an SCI Member and save on this and future events
See Membership Options
Sign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations
CPD Info
SCI Members attending this meeting are able to claim CPD points.
Additional Info
Organising Committee
Steve East, Evotec
Simon Peace, GlaxoSmithKline
Helen Sneddon, GlaxoSmithKline
David Pascoe, GlaxoSmithKline
Andy Wells, Charnwood Technical Consulting
Robert Bright, Pfizer
Chris Ashcroft, Pfizer